-
Loading metrics
Treatment Extension of Pegylated Interferon Alpha and Ribavirin Does Not Improve SVR in Patients with Genotypes 2/3 without Rapid Virological Response (OPTEX Trial): A Prospective, Randomized, Two-Arm, Multicentre Phase IV Clinical Trial
- Benjamin Heidrich,
- Hans-Jörg Cordes,
- Hartwig Klinker,
- Bernd Möller,
- Uwe Naumann,
- Martin Rössle,
- Michael R. Kraus,
- Klaus H. Böker,
- Christoph Roggel,
- Marcus Schuchmann
x
- Published: June 9, 2015
- https://doi.org/10.1371/journal.pone.0128069